V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019539 | 220014371 | 1.75 | 72.2 | Curative (C) | 2017-07-21 | 2017-08-29 | FLAG | N | N | 220030478 | FLAG |
| 220019541 | 220007978 | 1.65 | null | Curative (C) | 2014-11-05 | 2014-11-05 | ATG + Busulfan + Fludarabine | 02 | N | 220030495 | ATG + BUSULFAN + FLUDARABINE |
| 220019542 | 220014377 | null | 81.6 | Curative (C) | 2014-03-15 | 2014-03-27 | BOSUTINIB | Y | null | 220030497 | BOSUTINIB |
| 220019543 | 220007987 | 0 | null | Disease modification (D) | 2016-10-30 | 2016-11-05 | Idarubicin+Tretinoin Spanish Crse4 | 01 | N | 220030518 | IDARUBICIN + TRETINOIN |
| 220019544 | 220007991 | null | 87.8 | Disease modification (D) | 2013-11-04 | 2013-11-11 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220030524 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220019545 | 220007996 | 1.77 | 97.4 | null | null | 2014-12-31 | Idarubicin+Tretinoin Spanish Crse1 | 02 | Y | 220030530 | IDARUBICIN + TRETINOIN |
| 220019546 | 220014385 | 1.66 | null | Curative (C) | 2017-07-05 | 2018-05-01 | Idarubicin+Tretinoin Spanish Crse2 | 02 | N | 220030531 | IDARUBICIN + TRETINOIN |
| 220019547 | 220007999 | 1.6 | 46.9 | Curative (C) | 2016-03-14 | 2016-03-14 | Triple Intrathecal | N | N | 220030535 | TRIPLE INTRATHECAL |
| 220019548 | 220008005 | 1.67 | null | Curative (C) | 2015-03-03 | 2015-09-06 | AML16 Low Dose Cytarabine | 2 | N | 220030541 | AML16 TRIAL |
| 220019549 | 220008011 | 1.57 | 74.2 | null | 2015-02-23 | 2015-02-25 | CYCLOPHOSPHAMIDE | N | N | 220030561 | CYCLOPHOSPHAMIDE |
| 220019550 | 220008016 | null | 107.5 | Curative (C) | 2017-10-22 | 2017-10-23 | IDARUBICIN + TRETINOIN | N | N | 220030565 | IDARUBICIN + TRETINOIN |
| 220019551 | 220008020 | 1.67 | 52 | Disease modification (D) | 2015-04-20 | 2015-04-20 | IDARUBICIN + TRETINOIN | 2 | N | 220030571 | IDARUBICIN + TRETINOIN |
| 220019553 | 220008029 | 1.67 | 60 | Curative (C) | 2016-10-15 | 2016-10-16 | FLAG | 02 | null | 220030600 | FLAG |
| 220019554 | 220014398 | 1.85 | 81.4 | Curative (C) | 2016-03-23 | 2016-08-09 | AML16 DA 3+8 | N | N | 220030624 | AML16 TRIAL |
| 220019555 | 220014399 | 0 | 65 | null | null | 2014-12-20 | ADE 10+3+5 | N | N | 220030630 | ADE |
| 220019556 | 220008041 | 1.59 | 65 | Disease modification (D) | 2019-02-10 | 2019-02-16 | ATG + Busulfan + Fludarabine | 2 | N | 220030651 | ATG + BUSULFAN + FLUDARABINE |
| 220019557 | 220014402 | 1.6 | 76 | Curative (C) | 2018-03-07 | 2018-03-07 | ATG + Busulfan + Fludarabine | N | N | 220030653 | ATG + BUSULFAN + FLUDARABINE |
| 220019558 | 220008045 | null | 74.4 | Curative (C) | 2013-05-10 | 2013-08-26 | ATG + Busulfan + Fludarabine | 99 | N | 220030661 | ATG + BUSULFAN + FLUDARABINE |
| 220019559 | 220008050 | 1.63 | 106.8 | Disease modification (D) | 2015-12-31 | 2016-01-09 | Idarubicin+Tretinoin Spanish Crse4 | N | null | 220030685 | IDARUBICIN + TRETINOIN |
| 220019560 | 220008051 | null | 68.8 | Curative (C) | 2012-12-10 | 2013-04-15 | Cyclophosphamide TBI Allograft | N | null | 220030691 | CYCLOPHOSPHAMIDE |
| 220019561 | 220017862 | null | null | Adjuvant (A) | 2014-07-22 | 2014-07-22 | RUXOLITINIB | N | null | 220030693 | RUXOLITINIB |
| 220019562 | 220008060 | 0.99 | 39.2 | null | 2017-01-20 | 2017-12-16 | ATG + Busulfan + Fludarabine | null | N | 220030713 | ATG + BUSULFAN + FLUDARABINE |
| 220019563 | 220008062 | 1.62 | null | Palliative (P) | null | 2016-06-30 | FLAG | 2 | N | 220030719 | FLAG |
| 220019564 | 220008068 | 0 | null | Disease modification (D) | 2013-03-31 | 2013-05-19 | Triple Intrathecal | N | N | 220030733 | TRIPLE INTRATHECAL |
| 220019565 | 220014412 | null | 87 | Curative (C) | null | 2014-03-15 | Methotrexate Intrathecal (any age) | N | null | 220030735 | METHOTREXATE INTRATHECAL |
| 220019566 | 220008073 | null | 23.6 | Disease modification (D) | null | 2014-11-30 | Idarubicin+Tretinoin Spanish Crse2 | 02 | null | 220030737 | IDARUBICIN + TRETINOIN |
| 220019567 | 220008077 | null | 0 | Disease modification (D) | 2016-01-31 | 2016-01-31 | FLAG | null | N | 220030743 | FLAG |
| 220019568 | 220008083 | 1.79 | 80 | Curative (C) | 2014-05-17 | 2014-11-03 | Cyclophosphamide+Fludara+TBI Allo | Y | N | 220030754 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220019569 | 220008087 | 1.59 | 60.3 | Disease modification (D) | 2014-10-02 | 2014-10-02 | FLAG | N | N | 220030766 | FLAG |
| 220019570 | 220008089 | null | 58 | Disease modification (D) | 2016-10-13 | 2016-10-19 | Cyclophosphamide TBI Allograft | 99 | N | 220030766 | CYCLOPHOSPHAMIDE |
| 220019572 | 220020925 | null | null | Curative (C) | 2017-06-17 | 2017-09-03 | AML Int Guide ADE 8+3+5 (2) | N | N | 220030783 | ADE |
| 220019573 | 220008094 | 1.5 | 54.4 | Disease modification (D) | 2014-12-10 | 2014-12-11 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220030802 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220019574 | 220008095 | 1.85 | 71.75 | Disease modification (D) | 2015-08-14 | 2015-11-29 | FLAG | N | N | 220030807 | FLAG |
| 220019575 | 220008110 | 1.6 | 65 | Curative (C) | null | 2013-12-10 | IDARUBICIN + TRETINOIN | N | null | 220030849 | IDARUBICIN + TRETINOIN |
| 220019576 | 220008113 | 1.56 | 53.1 | Curative (C) | 2015-10-21 | 2016-11-06 | CYCLOPHOSPHAMIDE + FLUDARABINE | 99 | N | 220030865 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220019577 | 220008116 | 1.57 | 39.2 | null | 2018-05-10 | 2018-05-11 | Cyclophosphamide+Fludara+TBI Allo | 2 | Y | 220030880 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220019578 | 220008120 | 1.75 | 72.4 | Neo-adjuvant (N) | null | 2014-01-01 | IDARUBICIN + TRETINOIN | Y | N | 220030896 | IDARUBICIN + TRETINOIN |
| 220019580 | 220008135 | 1.66 | 55.9 | Disease modification (D) | 2017-06-19 | 2017-08-14 | RUXOLITINIB | N | N | 220030936 | RUXOLITINIB |
| 220019581 | 220014442 | 1.85 | 65.9 | Disease modification (D) | 2017-07-30 | 2017-08-07 | CYCLOPHOSPHAMIDE | 2 | N | 220030939 | CYCLOPHOSPHAMIDE |
| 220019582 | 220008140 | 0 | 61.2 | Disease modification (D) | 2013-01-30 | 2015-03-25 | Methotrexate intrathecal | Y | N | 220030950 | METHOTREXATE INTRATHECAL |
| 220019583 | 220008142 | 1.86 | 89 | Curative (C) | 2018-09-30 | 2018-09-30 | Idarubicin+Tretinoin Spanish Crse2 | Y | N | 220030955 | IDARUBICIN + TRETINOIN |
| 220019585 | 220008153 | null | null | 3 | 2014-03-03 | 2014-03-04 | FLAG | N | null | 220030962 | FLAG |
| 220019586 | 220014454 | 1.75 | null | null | 2018-07-11 | 2018-07-20 | BOSUTINIB | N | N | 220030983 | BOSUTINIB |
| 220019587 | 220008164 | 1.87 | 60 | Curative (C) | 2018-07-14 | 2018-12-14 | FLAG | 02 | N | 220030991 | FLAG |
| 220019589 | 220008168 | 0 | 59.9 | Disease modification (D) | 2013-07-11 | 2013-07-15 | AML Int Guide ADE 8+3+5 (2) | 02 | N | 220031002 | ADE |
| 220019590 | 220008175 | 1.77 | 95.3 | Disease modification (D) | 2016-10-18 | 2018-05-07 | FLAG | N | N | 220031027 | FLAG |
| 220019591 | 220008178 | 1.67 | 75 | null | 2010-08-17 | 2014-10-27 | Methotrexate intrathecal | 02 | N | 220031045 | METHOTREXATE INTRATHECAL |
| 220019592 | 220008180 | 1.65 | 74 | Curative (C) | 2016-07-15 | 2016-07-15 | AML16 Low Dose Cytarabine | 2 | N | 220031046 | AML16 TRIAL |
| 220019593 | 220021552 | null | 84 | Disease modification (D) | 2017-11-29 | 2017-12-14 | CYCLOPHOSPHAMIDE | N | null | 220031047 | CYCLOPHOSPHAMIDE |
| 220019594 | 220014464 | 1.68 | 85.7 | Palliative (P) | 2017-11-10 | 2017-11-10 | FLAG | N | N | 220031051 | FLAG |